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Lipoid proteinosis (Urbach-Wiethe disease, hyalinosis cutis et 
mucosae) is an autosomal-recessive condition with variable 
penetrance.  It is characterised by distinctive skin and 
mucous membrane lesions, particularly on the eyelids, on the 
extensor surface of large joints and in the mouth.  Laryngeal 
involvement is typical and causes hoarseness due to lesions on 
and around the vocal cords and occurs in 75% of patients with 
the condition.1 Patients are normally hoarse from infancy, and 
a chronic and benign course is usual.2 Lesions are found in the 
interarytenoid areas and on the aryepiglottic folds. Later, the 
true and false cords may be involved and airway compromise 
may develop.3 Excision of the lesions using microlaryngoscopy 
instruments has been shown to improve the airway and 
quality of the voice. Rarely, tracheostomy has been required to 
ensure a safe airway.4,5 There is no proven treatment for lipoid 
proteinosis.  Although both oral dimethyl sulphoxide and oral 
etretinate have shown promising results, recent case reports 
have found them to be ineffective.6  CO2 laser has been used 
successfully to treat eyelid deposits in lipoid proteinosis, but 
to the best of our knowledge it has not previously been used to 
treat laryngeal deposits.7
Case report
A 34-year-old man with the surname of Cloete, from Okiep 
in Namaqualand, Northern Cape (600 km from Cape Town), 
previously proven on DNA testing to have lipoid proteinosis, 
was referred to the ENT Department at Tygerberg Hospital, 
Cape Town, for an assessment of his airway and possible 
tracheostomy.  He had been hoarse since early childhood but 
had developed stridor 3 months before his referral. He is an 
epileptic on carbamazepine and smokes 40 cigarettes a day. His 
brother is also hoarse but has no airway difficulty. 
On examination, he had typical lipoid proteinosis skin 
lesions on the eyelids, the back of the hands, the elbows and 
the sacrum.  He had inspiratory and expiratory stridor, but did 
not have other signs of respiratory distress. Cardiorespiratory, 
abdominal and neurological examinations were otherwise 
normal. Fibreoptic laryngoscopy was performed, which 
revealed a compromised airway with florid lipoid proteinosis 
deposits throughout the supraglottic, glottic and subglottic 
areas and involving both vocal cords.  The right vocal cord was 
fixed and the left vocal cord movement was reduced. 
Microlaryngoscopy was performed under general anaesthetic 
and a biopsy was taken, confirming the diagnosis of lipoid 
proteinosis of the larynx (Fig. 1). Hyperplastic squamous 
epithelium with an underlying fibroblastic stroma was found.  
Deeper cuts showed hyaline material arranged around blood 
vessels and glands.  A Congo red stain (for amyloid) was 
negative and a PAS stain (for mucin) was positive (Fig. 2).   
A staged procedure of laser excision/vaporisation of the 
lesions causing airway obstruction was performed using a 
CO2 laser (Sharplan 4000, Sharplan Industries, Tel Aviv, Israel).  
The superpulse facility was used at 10 watts.  Spot size was 
adjusted according to cutting or coagulation requirements.  
Initially the left side of the larynx was treated, significantly 
reducing the patient’s stridor.  Two weeks later he was again 
examined under anaesthetic and the right side of the larynx 
was treated. Postoperatively he had a much-improved airway 
with no stridor, although his voice remained hoarse. Follow-up 
was telephonic because of his unwillingness to travel the large 
distance between his home and the hospital.  He presented 
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Fig. 1. Laryngeal lipoid proteinosis before treatment.Corresponding author: G Kroukamp (mckrouk@iafrica.com)
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with mild stridor 2 years and 6 months postoperatively and 
requested a second treatment.  This was done in the same way 
as the first, again with significant improvement in the airway.  
Until this presentation, he had had no recurrence of his stridor 
and had not sought medical attention for breathing difficulties.
Discussion
Urbach and Wiethe first described the condition in Germany 
in 1929, but it is estimated that 25% of cases occur in South 
Africa, particularly in the Namaqualand region in the towns of 
Concordia, Okiep, Nababeep and Springbok. This is because 
of the ‘founder effect’, where a condition, rare in the original 
population, is carried to a new area by migration of one or 
more individuals within a small group and therefore becomes 
more common in the new population.  The original carrier of 
this condition has been found to be one Jacob Cloete, a German 
immigrant to the Cape in 1652.  His great-grandson Gerrit 
Cloete migrated to Namaqualand in 1742 and intermarried 
with the inhabitants of the area.1 As the area is somewhat 
isolated, consanguineous marriages were relatively common, 
leading to a relatively high proportion of homozygous affected 
individuals.1,2
The condition is caused by the recently discovered Q276X 
mutation in the extracellular matrix protein 1 gene (ECM1) and 
maps to chromosome 1q21.8 There is a primary perturbation 
in collagen metabolism resulting in the deposition of hyalin 
material in blood vessel walls and extracellular spaces. Calcific 
deposits in the hippocampal gyri of the temporal lobes cause 
epilepsy in 20% of cases and may also cause déjà vu experiences 
and hallucinations. Rare features include atrophic scars, 
and oesophageal, rectal and anal involvement.  Parotid duct 
obstruction has been described.  There is an association with 
diabetes and hypercholesterolaemia.1
Although laser has never been used for the laryngeal 
lesions, it seems to be an ideal treatment modality for this 
purpose. The CO2 laser is used extensively for both benign and 
malignant conditions of the larynx, including laryngeal cysts, 
polyps, nodules, papillomas, granulomas and carcinomas. It 
allows accurate excision of lesions under microscopic control, 
with minimal injury to surrounding normal tissue.  Its safety 
and efficacy for endolaryngeal use is well established.9,10  Its 
proposed use here would be most analogous to its use in 
juvenile laryngeal papillomatosis, where it is internationally 
accepted as the treatment of choice.10 Laser is preferable to 
surgical excision of laryngeal lesions because it is more precise 
and there is less bleeding as the laser coagulates while cutting.9
We propose that the CO2 laser is an ideal treatment modality 
for laryngeal lipoid proteinosis, for the reasons given above, 
and should be the treatment of choice in cases where airway 
compromise makes surgical treatment necessary. 
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Fig. 2. PAS stain showing mucin deposition and hyaline material.
February 2007, Vol. 97, No. 2  SAMJ
Pg 90-92.indd   92 1/19/07   1:46:10 PM
